CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 184,855 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05050877
NCT05050877N/ACompleted

Risk Factors and Prognosis of Adverse Cardiovascular and Kidney Events After Coronary Intervention - Cardiorenal ImprovemeNt Registry II

Guangdong Provincial People's Hospital·observational·Posted Sep 21, 2021·Updated Sep 21, 2021

In Brief

An observational study for Cardio-Renal Syndrome and 4 related conditions. Completed, enrolled 184,855 participants across 1 site.

Detailed Summary

As a multi-center, retrospective observation study in southern China, this study included the main study population of patients who underwent coronary angiography at 5 hospitals from Guangzhou, Shenzhen, Yangjiang, Maoming and Longyan from January 2000 to Decemeber 2020. The hospitalization information was collected in the form of direct derivation of the case, and cardiac and renal adverse events were collected through outpatient system. Data on all-cause death were obtained from the Guangdong Provincial Public Security and matched to the electronic Clinical Management System of the Guangdong Provincial People's Hospital records.

Study Details

Timeline

N/ACompletedFinished
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 21, 2021
Enrollment StartJun 1, 2000
Primary CompletionDec 31, 2020
TodayJul 2, 2026
Enrollment to primary: 20.6 yearsPosted 4.8 years ago